Word

TRANSTHERA

Status

Pending

Status Code

730

Status Date

Wednesday, November 22, 2023

Serial Number

97486232

Mark Type

3

Filing Date

Friday, July 1, 2022

Published for Opposition

Tuesday, April 11, 2023

Trademark Owner History

TransThera Sciences (Nanjing), Inc. - Owner At Publication

Classifications

5 Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders

The mark consists of the stylized wording "TransThera", wherein the stylized letter "n" in the wording has an elongated right side and a design with stylized leaves above and a curved line above the middle of the mark.
TRANS THERA
Color is not claimed as a feature of the mark.
The wording TransThera has no meaning in a foreign language.

Trademark Events

Jul 5, 2022

New Application Entered

Jul 22, 2022

New Application Office Supplied Data Entered

Jul 23, 2022

Notice Of Design Search Code E-Mailed

Feb 25, 2023

Assigned To Examiner

Mar 2, 2023

Examiners Amendment -Written

Mar 2, 2023

Examiners Amendment E-Mailed

Mar 2, 2023

Notification Of Examiners Amendment E-Mailed

Mar 2, 2023

Examiner's Amendment Entered

Mar 2, 2023

Approved For Pub - Principal Register

Mar 22, 2023

Notification Of Notice Of Publication E-Mailed

Apr 11, 2023

Published For Opposition

Apr 11, 2023

Official Gazette Publication Confirmation E-Mailed

Nov 22, 2023

Sou Teas Extension Received

Nov 22, 2023

Sou Extension 1 Filed

Jun 6, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 22, 2023

Sou Extension 1 Granted

Nov 24, 2023

Notice Of Approval Of Extension Request E-Mailed

Jun 5, 2024

Teas Petition To Amend Basis Received